SELLAS Life Sciences Group (SLS) Retained Earnings: 2011-2024
Historic Retained Earnings for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to -$241.4 million.
- SELLAS Life Sciences Group's Retained Earnings fell 15.44% to -$241.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$241.4 million, marking a year-over-year decrease of 15.44%. This contributed to the annual value of -$217.2 million for FY2023, which is 20.76% down from last year.
- SELLAS Life Sciences Group's Retained Earnings amounted to -$241.4 million in Q3 2024, which was down 3.03% from -$234.3 million recorded in Q2 2024.
- SELLAS Life Sciences Group's Retained Earnings' 5-year high stood at -$105.3 million during Q1 2020, with a 5-year trough of -$241.4 million in Q3 2024.
- For the 3-year period, SELLAS Life Sciences Group's Retained Earnings averaged around -$199.1 million, with its median value being -$199.8 million (2023).
- Data for SELLAS Life Sciences Group's Retained Earnings shows a maximum YoY crashed of 31.12% (in 2022) over the last 5 years.
- SELLAS Life Sciences Group's Retained Earnings (Quarterly) stood at -$117.9 million in 2020, then fell by 17.56% to -$138.6 million in 2021, then dropped by 29.80% to -$179.9 million in 2022, then fell by 20.76% to -$217.2 million in 2023, then dropped by 15.44% to -$241.4 million in 2024.
- Its Retained Earnings stands at -$241.4 million for Q3 2024, versus -$234.3 million for Q2 2024 and -$226.8 million for Q1 2024.